How would you manage a patient with well controlled HIV on Biktarvy, who is interested in switching to injectable HAART but also has a history of a prior Hepatitis B Infection?  

HBV is a common co-infection in people with HIV (PWH), due to shared transmission routes. Two large meta-analyses of studies published found a global a pooled prevalence of HBV infection among PWH to be between 7.6 and 8.4%, with a higher prevalence in less developed countries (10.4%) compared to mo...

I agree with the below; it is not typically recommended to switch to Cabenuva (cabotegravir + rilpivirine) in patients with active HBV infection (positive HBsAg), as it does not provide any coverage for this infection. If for some reason the patient wanted the Cabenuva and didn't mind taking some ex...